Literature DB >> 3561413

Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences.

V P Stanton, G M Cooper.   

Abstract

Three activated cellular raf genes have been detected by transfection of NIH 3T3 cells with human tumor DNAs. Blot hybridization analysis indicated that all three transforming raf genes had recombined with non-raf sequences in the vicinity of raf exon 7-intron 7, resulting in the deletion of about 40% of the normal coding sequence from the raf amino terminus. By cloning sequences upstream of the truncated raf loci we have shown that the rearrangements involve the fusion of three different 5' non-raf human sequences to the human raf gene. No rearrangements could be detected in the raf loci of the three original human tumor DNAs, suggesting that the raf genes were activated by DNA rearrangements occurring during transfection. Significant overexpression of raf mRNA was not evident in two of the three transformant lines, indicating that raf overexpression is not necessary and 5' truncation alone may be sufficient to activate the transforming potential of cellular raf genes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3561413      PMCID: PMC365190          DOI: 10.1128/mcb.7.3.1171-1179.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  Characterization of an activated human ros gene.

Authors:  C Birchmeier; D Birnbaum; G Waitches; O Fasano; M Wigler
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

2.  Ribonucleic acid isolated by cesium chloride centrifugation.

Authors:  V Glisin; R Crkvenjakov; C Byus
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

3.  The mouse c-abl locus: molecular cloning and characterization.

Authors:  J Y Wang; F Ledley; S Goff; R Lee; Y Groner; D Baltimore
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

4.  Gene product of v-fgr onc: hybrid protein containing a portion of actin and a tyrosine-specific protein kinase.

Authors:  G Naharro; K C Robbins; E P Reddy
Journal:  Science       Date:  1984-01-06       Impact factor: 47.728

5.  Differential activation of two protease-activated protein kinases from reticulocytes by a Ca2+-stimulated protease and identification of phosphorylated translational components.

Authors:  S M Tahara; J A Traugh
Journal:  Eur J Biochem       Date:  1982-08

6.  Transformation by subgenomic fragments of Rous sarcoma virus DNA.

Authors:  N G Copeland; A D Zelenetz; G M Copper
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

7.  Transforming activity of DNA of chemically transformed and normal cells.

Authors:  G M Cooper; S Okenquist; L Silverman
Journal:  Nature       Date:  1980-04-03       Impact factor: 49.962

8.  Ubiquitous, interspersed repeated sequences in mammalian genomes.

Authors:  W R Jelinek; T P Toomey; L Leinwand; C H Duncan; P A Biro; P V Choudary; S M Weissman; C M Rubin; C M Houck; P L Deininger; C W Schmid
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Homologous cell-derived oncogenes in avian carcinoma virus MH2 and murine sarcoma virus 3611.

Authors:  H W Jansen; R Lurz; K Bister; T I Bonner; G E Mark; U R Rapp
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

10.  The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb.

Authors:  K H Klempnauer; G Ramsay; J M Bishop; M G Moscovici; C Moscovici; J P McGrath; A D Levinson
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

View more
  29 in total

1.  Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.

Authors:  Yafei Li; Zhifu Sun; Julie M Cunningham; Marie C Aubry; Jason A Wampfler; Gary A Croghan; Cassandra Johnson; Danli Wu; Jeremiah A Aakre; Julian Molina; Liewei Wang; V Shane Pankratz; Ping Yang
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

2.  Development of a highly efficient expression cDNA cloning system: application to oncogene isolation.

Authors:  T Miki; T P Fleming; M Crescenzi; C J Molloy; S B Blam; S H Reynolds; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Autoregulation of the Raf-1 serine/threonine kinase.

Authors:  R E Cutler; R M Stephens; M R Saracino; D K Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

4.  Induction of transformation and DNA synthesis after microinjection of raf proteins.

Authors:  M R Smith; G Heidecker; U R Rapp; H F Kung
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

Review 5.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

6.  Definition of the human raf amino-terminal regulatory region by deletion mutagenesis.

Authors:  V P Stanton; D W Nichols; A P Laudano; G M Cooper
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

7.  Developmentally regulated expression of a human "finger"-containing gene encoded by the 5' half of the ret transforming gene.

Authors:  M Takahashi; Y Inaguma; H Hiai; F Hirose
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

8.  The predicted DBL oncogene product defines a distinct class of transforming proteins.

Authors:  A Eva; G Vecchio; C D Rao; S R Tronick; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.

Authors:  Hengyu Lu; Nicole Villafane; Turgut Dogruluk; Caitlin L Grzeskowiak; Kathleen Kong; Yiu Huen Tsang; Oksana Zagorodna; Angeliki Pantazi; Lixing Yang; Nicholas J Neill; Young Won Kim; Chad J Creighton; Roel G Verhaak; Gordon B Mills; Peter J Park; Raju Kucherlapati; Kenneth L Scott
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

Review 10.  Aberrant function of the Ras signal transduction pathway in human breast cancer.

Authors:  G J Clark; C J Der
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.